tak 779 has been researched along with lamivudine in 3 studies
| Studies (tak 779) | Trials (tak 779) | Recent Studies (post-2010) (tak 779) | Studies (lamivudine) | Trials (lamivudine) | Recent Studies (post-2010) (lamivudine) |
|---|---|---|---|---|---|
| 118 | 1 | 35 | 7,025 | 1,425 | 2,177 |
| Protein | Taxonomy | tak 779 (IC50) | lamivudine (IC50) |
|---|---|---|---|
| Capsid protein | Hepatitis B virus | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariën, KK; Arts, EJ; Colebunders, RL; Gali, Y; Troyer, RM; Vanham, G | 1 |
| Heil, M; Jones, J; Kutsch, O; Ochsenbauer-Jambor, C; Zammit, KP | 1 |
| Arts, EJ; Lobritz, MA; Marozsan, AJ; Troyer, RM | 1 |
3 other study(ies) available for tak 779 and lamivudine
| Article | Year |
|---|---|
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time.
Topics: Amides; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; Dendritic Cells; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Phylogeny; Quaternary Ammonium Compounds; Viral Load; Virulence; Virus Replication | 2005 |
T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication.
Topics: Amides; Anti-HIV Agents; Biomarkers; CCR5 Receptor Antagonists; Cell Culture Techniques; Cell Line; Genes, Reporter; Green Fluorescent Proteins; HIV Antibodies; HIV Fusion Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Microbial Sensitivity Tests; Microscopy, Fluorescence; Quaternary Ammonium Compounds; Reverse Transcriptase Inhibitors; RNA, Viral; T-Lymphocytes; Virus Replication | 2006 |
Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity.
Topics: Amides; Amino Acid Sequence; Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; Cell Line; Chemokine CCL5; Drug Resistance, Viral; Genetic Variation; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV-1; Humans; Lamivudine; Macrophages; Models, Molecular; Peptide Fragments; Protein Structure, Tertiary; Quaternary Ammonium Compounds; Receptors, CCR5; Virus Replication | 2007 |